BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19151111)

  • 1. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
    Masood S; Jayne D; Karim Y
    Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for lupus nephritis: a revisit.
    Lai KN; Tang SC; Mok CC
    Nephrology (Carlton); 2005 Apr; 10(2):180-8. PubMed ID: 15877679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
    Boumpas DT; Sidiropoulos P; Bertsias G
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 2000 May; 20(3):265-76. PubMed ID: 10855936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric lupus nephritis: more options, more chances?
    Vachvanichsanong P; McNeil E
    Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lupus nephritis.
    Austin HA; Boumpas DT
    Semin Nephrol; 1996 Nov; 16(6):527-35. PubMed ID: 9125797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical approach to lupus nephritis: recent advances.
    Molino C; Fabbian F; Longhini C
    Eur J Intern Med; 2009 Sep; 20(5):447-53. PubMed ID: 19712841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of immunosuppressive drugs in the treatment of lupus nephritis.
    Klippel JH; Austin HA; Balow JE; leRiche NG; Steinberg AD; Plotz PH; Decker JL
    Rheum Dis Clin North Am; 1987 Apr; 13(1):47-56. PubMed ID: 3306824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of proliferative lupus nephritis--a critical approach.
    Buhaescu I; Covic A; Deray G
    Semin Arthritis Rheum; 2007 Feb; 36(4):224-37. PubMed ID: 17067659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.
    Liang L; Yang X; Xu H; Zhan Z; Ye Y; Yu X; Chen W
    J Rheumatol; 2004 Apr; 31(4):701-6. PubMed ID: 15088294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():13-8. PubMed ID: 12583308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus nephritis].
    Morović-Vergles J; Salamon L
    Reumatizam; 2009; 56(2):34-40. PubMed ID: 20429260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].
    Anić B; Crkvencić N; Mayer M; Bosnić D; Sentić M; Markeljević J; Cikes N
    Lijec Vjesn; 1999; 121(9-10):283-8. PubMed ID: 19658369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolated microhematuria as the manifestation of lupus nephritis].
    Shvetsov MIu; Kozlovskaia NL
    Ter Arkh; 1996; 68(1):57-8. PubMed ID: 8644035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.